BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Day, and welcome to the BioCryst First Quarter twenty twenty six Earnings Conference Call. All participants will be in listen only mode. Please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Nick Wilder. Please go ahead. Good morning, and welcome to BioCryst's first quarter twenty twenty six corporate update and financial results conference call. Participating with me today are President and CEO, Charlie Guyer Chief R and D Officer, Doctor. Sandeep Menon and Chief Financial Officer, Bob Raghiyev. A press release and slide presentation about today's news are available on our Investor Relations website. Today's call contains forward looking statements, including statements regarding future results, unaudited and forward looking financial information, as well as the company's future performance and or achievements. These statements are subject to known and unknown risks and uncertainties, which may cause our actual results, performance, or achievements to be materially different from any future results or performance expressed or implied in this presentation. For additional information, including a detailed discussion of these risks, please refer to slide two of the presentation. In addition, today's conference call includes non GAAP financial measures. For a reconciliation of these non GAAP financial measures against the most directly comparable GAAP financial measure, please refer to the earnings press release available on our Investor Relations website. I'd now like to turn the call over to Charlie. Thanks, Nick. 2026 is off to a very good start for BioCryst, marked by strong ex...